Insights
Search Results
News Articles
5.30.25
Wilson Sonsini, Attorneys Honored in 2025 IAM Patent 1000
On May 29, 2025, IAM 1000 recognized Wilson Sonsini in the 2025 edition of IAM Patent 1000. The guide honored the firm with three firm rankings and six Wilson Sonsini attorneys received individual recommendations in the rankings.
News Articles
6.06.24
2024 IAM Patent 1000 Recognizes Wilson Sonsini, Attorneys
On June 5, 2024, IAM 1000 recognized Wilson Sonsini in the 2024 edition of "IAM Patent 1000 – The World’s Leading Patent Practitioners." The guide honored the firm with three firm rankings and six Wilson Sonsini attorneys received individual recommendations in the rankings.
News Articles
9.14.23
Wilson Sonsini Attorneys Recognized in 2023 IAM Patent 1000
IAM Patent 1000 has recognized Wilson Sonsini in its newly published 2023 edition of IAM Patent 1000 – The World’s Leading Patent Practitioners. The guide recognized the firm with three firm rankings and six Wilson Sonsini attorneys received individual recommendations in the rankings.
News Articles
10.05.22
Wilson Sonsini and Attorneys Recognized in 2022 Edition of LMG Life Sciences
LMG Life Sciences recognized several Wilson Sonsini practices and 16 of its attorneys in the 2022 edition of its guide, which identifies and ranks the leading law firms and individuals in the life sciences industry.
Client Highlights
9.30.21
Firm Advises Activ Surgical on IP Matters Related to $45 Million Series B Financing
On September 30, 2021, Activ Surgical, a digital surgery pioneer, announced that it has raised $45 million in a Series B financing round. The financing was led by Cota Capital and included participation from new investors, including BAM Funds, Magnetar Capital, MINT Venture Partners, Castor Ventures, Dream One Vision, and NVIDIA, as well as existing investors DNS Capital, Tao Capital Partners, LRVHealth, Rising Tide VC, GreatPoint Ventures (GPV), and ARTIS Ventures.
Client Highlights
4.29.21
Wilson Sonsini Advises Ceribell on $53 Million Series C Financing
On April 29, 2021, Ceribell, innovator of the Rapid Response EEG™, a novel non-invasive brain monitor, announced the completion of a $53 million Series C financing, which was co-led by Longitude Capital and The Rise Fund. Other new investors include RA Capital Management, Redmile Group, and Red Tree Venture Capital, with additional support from existing shareholders. Wilson Sonsini Goodrich & Rosati represented Ceribell in the transaction.
Client Highlights
2.26.21
Wilson Sonsini Advises Simplify Medical in Its Acquisition by NuVasive
On February 24, 2021, NuVasive, Inc., the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, announced that it has acquired Simplify Medical, a privately held company and developer of the Simplify® Cervical Artificial Disc (Simplify Disc) for cervical total disc replacement (cTDR). Wilson Sonsini Goodrich & Rosati represented Simplify Medical in the transaction.
Client Highlights
11.12.20
Wilson Sonsini Advises Relign in Acquisition by Zimmer Biomet
On November 6, 2020, Zimmer Biomet, a leading medical device manufacturer, announced in its earnings report that it has acquired Relign Corp., a privately held start-up in the growing $1.6 billion arthroscopy market and overall $5 billion sports medicine market. Relign’s offerings include the consolidation of three differentiated arthroscopy tower components into a single system, a first in the industry, and address a key portfolio gap for Zimmer Biomet in the sports medicine and broader ambulatory surgery center markets.